Grown Rogue International Inc. (GRUSF) said its affiliate SEA Craft LLC completed its first deliveries of Grown Rogue products to select Illinois dispensaries this week, bringing the brand into the state’s cannabis market. Cultivation at SEA Craft’s Dwight facility restarted in June 2026 after state approval on June 5.
The initial flowering canopy is approximately 5,000 square feet, with work underway to expand it to approximately 10,000 square feet. Grown Rogue said the pace of additional capacity will be informed by operating performance and market demand, subject to applicable regulatory requirements. The company reported 50 people working at Dwight.
Grown Rogue International Inc. completed the exercise of its second option to acquire an additional 26% ownership interest in New Jersey subsidiary ABCO Garden State, LLC, bringing its ownership to 70%. The option was conditional on approval from the New Jersey Cannabis Regulatory Commission, which was received on September 16, 2026. Grown Rogue also took majority control of ABCO’s board. The approximately US$743,000 purchase price was advanced to ABCO in 2023.
Grown Rogue says it remains on schedule for Phase II construction in New Jersey to be substantially complete by the end of 2026. The planned expansion is expected to bring total New Jersey flowering canopy to approximately 16,000 square feet, with additional production capacity ramping into 2027.
Grown Rogue International Inc. will release its third-quarter 2026 financial results after market close on Thursday, November 12, 2026, and hold a conference call that day at 5:00 p.m. ET / 2:00 p.m. PT. CEO Obie Strickler and members of management will host the call, followed by a question-and-answer period. A telephone replay will be available through November 19, 2026, and a transcript will be posted on the company’s Investor Relations website.
Grown Rogue International Inc. (GRUSF) announced that cultivation activities have begun at its affiliated licensed cultivation facility in Fridley, Minnesota, after receiving approval to operate from Minnesota's Office of Cannabis Management on August 25, 2026. This marks a key step in the company’s expansion into the Minnesota cannabis market.
Phase I includes approximately 8,000 square feet of flowering canopy across five flower rooms within an approximately 109,000-square-foot facility, which can ultimately support the current regulatory limit of about 30,000 square feet of flowering canopy. All five flower rooms are built, with plants being introduced sequentially. The first harvest is expected in late fourth quarter 2026, and products are expected to reach Minnesota consumers in the first quarter of 2027.
Grown Rogue International Inc. (GRUSF) is asking shareholders at the October 26, 2026 annual and special meeting to elect four directors, re‑appoint Turner, Stone & Company, L.L.P. as auditors, approve an amended and restated equity incentive plan, and approve a potential share consolidation of up to one-for-thirty.
The amended equity plan would cap Subordinate Voting Shares issuable under all awards at 15% of shares outstanding, down from 20%, with a rolling reserve feature for options and an unchanged cap of 20,000,000 shares for incentive stock options. As of June 30, 2026, there were 249,938,980 Subordinate Voting Shares outstanding, with directors and officers as a group holding 43,288,373 shares (about 17.3%), and Mindset Capital LLC and J. Obie Strickler holding significant stakes. The proxy also details executive and director compensation, option and RSU grants, and extensive related‑party debt and lease arrangements with the CEO, a general manager, and ABCO Holdings, Inc.
Grown Rogue International Inc. (GRUSF) is entering the New York cannabis market through a planned acquisition of PharmaCann Inc.’s New York license and assets via a new joint venture, Grown Rogue New York, LLC (GRNY), owned 51% by Grown Rogue and 49% by a capital partner.
The capital partner invested $10 million for preferred equity in GRNY and committed an additional $5 million drawable term loan, forming up to $15 million in project-based financing. The preferred equity is convertible into up to 18.2 million subordinate voting shares, about 7% dilution if fully converted at current terms.
GRNY is managing PCNY’s four Verilife dispensaries and Hamptonburgh, New York cultivation/processing facility under a Goods and Services Agreement and a secured loan of up to $9 million. The anticipated purchase price for PCNY’s license and assets is about $4.5 million, subject to definitive agreements and regulatory approvals. Management estimates roughly $20 million in annual cost reductions and targets after-tax operating cash flow of about $600,000 per month within 18 months from the New York operations.
Grown Rogue International Inc. (GRUSF) is asking shareholders to vote at its October 26, 2026 annual and special meeting on several key items: electing four directors, re-appointing Turner, Stone & Company, L.L.P. as auditors, approving an amended and restated equity incentive plan, and authorizing a share consolidation of up to one new share for every thirty existing shares. As of June 30, 2026, there were 249,938,980 Subordinate Voting Shares outstanding, all of the company’s voting power; no Multiple Voting Shares were outstanding.
The amended equity plan would reduce the maximum equity overhang from 20% of outstanding shares (49,987,796 shares) to 15% (37,490,847 shares based on current outstanding), while keeping a separate 20,000,000-share cap for incentive stock options and introducing a rolling reserve feature for options. Major holders include Mindset Capital LLC with 15.27% and CEO J. Obie Strickler with 13.94%; directors and officers as a group hold 17.3%. The proxy also details related-party leases and acquisition payables involving the CEO and a general manager, and discloses past Canadian cease-trade or management cease-trade orders affecting companies where director Stephen Gledhill held roles.
Grown Rogue International Inc., a multi-state cannabis cultivator and distributor, delivered strong top-line growth but moved back into losses in 2026. Revenue for the six months ended June 30, 2026 was $20,429,495, up from $15,160,170 in 2025, with gross profit of $9,327,611 and positive income from operations. Consolidated net loss was $3,694,415, including a loss attributable to shareholders of $4,395,053, compared with net income of $2,398,248 and $2,098,757 respectively a year earlier; basic and diluted EPS were a loss of $0.02 for the first half.
Operating cash flow improved to $4,247,865, and cash and cash equivalents were $11,532,826 against long-term debt of $12,733,162. An uncertain tax liability related primarily to U.S. cannabis tax rules under IRC Section 280E rose to $9,830,257, driving a high effective tax rate. Equity attributable to shareholders declined to $15,294,416, partly offset by higher non-controlling interests after selling a 20% stake in GRMA for net proceeds of $2,985,000 to support Illinois expansion. The company continues investing in facilities in Illinois and Minnesota while operating in a U.S. market where cannabis remains a Schedule I controlled substance at the federal level, which the company notes could affect its ability to continue as a going concern if enforcement policies change.
Grown Rogue International Inc. reported Q2 2026 results with revenue of $11.3 million, up 41% from $8.0 million a year earlier. Gross profit was $5.4 million, reflecting a gross margin of 47.6%. Adjusted EBITDA was $2.1 million (18.2% margin), while GAAP results showed a net loss of $1.5 million versus prior-year net income of $1.7 million.
By market, Q2 revenue was $3.5 million in Oregon, $3.4 million in Michigan and $4.4 million in New Jersey, where Adjusted EBITDA margin reached 42.2%. Cash and cash equivalents were $11.5 million as of June 30 2026. Management increased 2026 and 2027 guidance, targeting consolidated gross margins above 42% in 2026 and above 44% in 2027, supported by expansion of flowering canopy in New Jersey, Illinois and Minnesota.
Conacher Sean reported acquisition or exercise transactions in this Form 4 filing.
Grown Rogue International Inc. director Sean Conacher received a grant of 120,000 Restricted Stock Units (RSUs) on July 21, 2026 under the company’s equity incentive plan. Each RSU represents one subordinate voting share and will vest in full on the earlier of January 1, 2029 or his termination of service. Following this award, he directly holds 120,000 RSUs, which do not expire.